Literature DB >> 22505531

Percentage of hypochromic erythrocytes as a potential marker of iron availability.

Eloísa Urrechaga1, Luís Borque, Jesús F Escanero.   

Abstract

BACKGROUND: The percentage of hypochromic red cells (% Hypo-He) is now available on the Sysmex analyzer XE 5000 (Sysmex Corporation, Kobe, Japan). In this study the reliability of % Hypo-He in the assessment of iron status in the presence of inflammation is investigated.
METHODS: Ninety healthy subjects, 91 patients with iron deficiency anemia (IDA) previous to therapy, 65 patients with chronic kidney disease (CKD), 57 patients with anemia of chronic diseases (ACD) and 28 patients with storage iron deficiency (ACD/IDA) receiving therapy were analyzed. Pearson's correlation, Independent samples t-test, receiver operating characteristic (ROC) curve analysis and Cohen's k index were applied.
RESULTS: % Hypo-He values inversely correlated with the blood hemoglobin (Hb) (r=-0.78) and Hb content (MHC, r=-0.75). In patients with IDA and ACD/IDA the values obtained for % Hypo-He showed no statistical difference (p=0.5037). ROC analysis results for % Hypo-He in the detection of iron deficiency defined by a serum transferrin receptor (sTfR) >21 nmol/L. The area under the curve is 0.929; cut-off 3.6%, sensitivity 91.5% and specificity 80.9%. Using the threshold 3.6% the k index obtained in comparison to sTfR was 0.64.
CONCLUSIONS: % Hypo-He is a reliable parameter for the detection of iron deficiency in patients with anemia in the presence of inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22505531     DOI: 10.1515/cclm.2011.837

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Clinical Value of Hypochromia Markers in the Detection of Latent Iron Deficiency in Nonanemic Premenopausal Women.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  J Clin Lab Anal       Date:  2016-02-22       Impact factor: 2.352

2.  Iron deficiency in newborn infants: global rewards for recognizing and treating this silent malady.

Authors:  Robert D Christensen; Timothy M Bahr; Diane M Ward
Journal:  Newborn (Clarksville)       Date:  2022-03-31

3.  Urinary ferritin; a potential noninvasive way to screen NICU patients for iron deficiency.

Authors:  Erick Gerday; Jennifer B Brereton; Timothy M Bahr; Jennifer O Elmont; Susan Fullmer; Bruce A Middleton; Diane M Ward; Robin K Ohls; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-24       Impact factor: 3.225

Review 4.  Diagnosis and treatment of anemia in patients with inflammatory bowel disease.

Authors:  Victoria Mücke; Marcus M Mücke; Tim Raine; Dominik Bettenworth
Journal:  Ann Gastroenterol       Date:  2016-09-06

5.  Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.

Authors:  Panagiota Xanthouli; Vivienne Theobald; Nicola Benjamin; Alberto M Marra; Anna D'Agostino; Benjamin Egenlauf; Memoona Shaukat; Cao Ding; Antonio Cittadini; Eduardo Bossone; Maria Kögler; Ekkehard Grünig; Martina U Muckenthaler; Christina A Eichstaedt
Journal:  Respir Res       Date:  2021-11-09

6.  Diagnostic utility of low hemoglobin density to detect iron deficiency in patients with inflammatory bowel disease.

Authors:  Karima Farrag; Krenare Ademaj; Eleni Leventi; Aysegül Aksan; Jürgen Stein
Journal:  Ann Gastroenterol       Date:  2021-04-02

Review 7.  Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.